Shining a Light on Makhauhelo’s Gratitude

Shining a Light on Makhauhelo’s Gratitude

Makhauhelo’s life has been full of ups and downs since being diagnosed with chronic myeloid leukemia (CML). She remembers the fear of not having access to the medication she needed, but also the kindness of healthcare providers who never stopped searching for a solution.

In 2017, Makhauhelo began experiencing weakness and fatigue. Her daughter, who was a nurse at a local hospital in Lesotho, arranged for an appointment there. Makhauhelo was shocked to see her daughter crying after talking with the doctor.

“The doctor explained that the disease had already progressed significantly,” she said. “He told me he didn’t even know how I was still alive. Then he asked whether I had my passport with me.”

Makhauhelo was transferred to a hospital in South Africa. After two weeks of treatment, she was discharged and told the CML medication she needed would be over $3,000.

“I didn’t have that kind of money,” she says. “I was sent home without medicine and told to return only when I could afford it.”

Before she left, one of the doctors there introduced her to a patient assistance program that had previously helped his father, who also had CML. Makhauhelo started receiving medication a few months later. She was overjoyed by the news.

After two years, the international assistance program ended. She felt the familiar worry of wondering what would happen next, and how she would get the treatment she needed. Thankfully, she was able to access it locally.

In 2025, Makhauhelo started receiving treatment free of charge through our new CML program in Lesotho. In partnership with local healthcare professionals, we provide access to diagnostics, medication, and support services. Dr. Kabelo Mputsoe, the first oncologist in the country, has spent the last several years building up the clinic and caring for residents living with cancer.

“This has changed my life,” Makhauhelo said. “I don’t have to worry about running out of medicine anymore. I come for my appointments, collect my treatment, and continue living my life.”

She’s grateful for the hope this program brought to Lesotho. And now that she’s feeling better, she can focus on spending time with her family.

“I am alive because people cared enough not to give up on me,” Makhauhelo said. “Cancer is not the end of life. There is hope. Take your treatment, keep your appointments, and never lose faith.”

The Max Foundation is a leading global health nonprofit organization dedicated to accelerating health equity. For 28 years, Max has pioneered practical, scalable, high-quality solutions to bring life-extending treatments and patient-centered health care to more than 100,000 people living with cancer and critical illness in low- and middle-income countries. Max believes in a world where all people can access high-impact medicines, where geography is not destiny, and where everyone can strive for health with dignity and with hope.

Related Articles

  • Remembering Max

    Remembering Max

    Year after year I dread this day, March 9th, the day cancer took Max from us. No matter how many years pass, how excited I might be about our progress, our goals and vision for the future, as the day approaches, I feel a dark cloud settling in. Suddenly I am back to 1991 and….

  • Leading the Way in Drug Quality and Patient Safety

    Leading the Way in Drug Quality and Patient Safety

    The Max Foundation leads the way in developing systems to ensure adverse event reports are shared promptly with local health authorities through prescribers, and with drug manufacturers alike.

  • From first symptoms to finding an effective treatment

    From first symptoms to finding an effective treatment

    The journey from experiencing the first symptoms of chronic myeloid leukemia (CML) to finding an effective treatment can be long, difficult, and painful, especially in low- and middle-income countries. That was the case for Chamu from Harare, Zimbabwe. It took him more than a year to get a diagnosis, but he kept fighting and is….